PharmaCyte Biotech Discusses Future of Cannabis Research Program, Competitors and More with Program’s Director
April 18, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s Cannabis Research Program Sees Significant Progress in University of Northern Colorado Presentations
April 10, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development
April 03, 2017 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., April 03, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing
March 22, 2017 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech CEO Addresses IND Submission Questions
March 17, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., March 17, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Names Dr. Leonard Makowka as Senior Strategic Advisor
March 13, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial
February 21, 2017 09:25 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity
February 13, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Releases Shareholder Call and Complete Q&A Playback Information
February 08, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using...
PharmaCyte Biotech Provides Update for February 7th Shareholder Call
February 02, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using...